GN
Ghulam Nabi Mir
About Ghulam Nabi Mir
Data last updated:
Ghulam Nabi Mir is a Director at Carter Walc Pharmaceuticals Private Limited (since 2024). The company operates in Business Services. Carter Walc Pharmaceuticals Private Limited reported revenue of ₹5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Carter Walc Pharmaceuticals Private Limited U74999DL2021PTC390687 | Director | 15 Sep 2024 | 2021 | ₹5 Lakh (FY 2025) | Active |
Board colleagues of Ghulam Nabi Mir
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ibraq | 09420341 | Carter Walc Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ghulam Nabi Mir
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ghulam Nabi Mir
Ghulam Nabi Mir currently holds 1 directorship: Carter Walc Pharmaceuticals Private Limited (Director, since 15 Sep 2024, revenue ₹5 Lakh (FY 2025)).
Ghulam Nabi Mir was first appointed on 15 Sep 2024 as Director at Carter Walc Pharmaceuticals Private Limited.
The current boards of Ghulam Nabi Mir's companies include Ibraq (Carter Walc Pharmaceuticals Private Limited).